JP2011509282A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509282A5
JP2011509282A5 JP2010541840A JP2010541840A JP2011509282A5 JP 2011509282 A5 JP2011509282 A5 JP 2011509282A5 JP 2010541840 A JP2010541840 A JP 2010541840A JP 2010541840 A JP2010541840 A JP 2010541840A JP 2011509282 A5 JP2011509282 A5 JP 2011509282A5
Authority
JP
Japan
Prior art keywords
furo
benzamide
pyrrole
oxodihydro
oxopentan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010541840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509282A (ja
JP5587790B2 (ja
Filing date
Publication date
Priority claimed from GB0800338A external-priority patent/GB0800338D0/en
Priority claimed from GB0808669A external-priority patent/GB0808669D0/en
Application filed filed Critical
Priority claimed from PCT/GB2009/000039 external-priority patent/WO2009087379A2/en
Publication of JP2011509282A publication Critical patent/JP2011509282A/ja
Publication of JP2011509282A5 publication Critical patent/JP2011509282A5/ja
Application granted granted Critical
Publication of JP5587790B2 publication Critical patent/JP5587790B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010541840A 2008-01-09 2009-01-07 化合物 Expired - Fee Related JP5587790B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0800338A GB0800338D0 (en) 2008-01-09 2008-01-09 Compounds
GB0800338.6 2008-01-09
GB0808669.6 2008-05-13
GB0808669A GB0808669D0 (en) 2008-05-13 2008-05-13 Compounds
PCT/GB2009/000039 WO2009087379A2 (en) 2008-01-09 2009-01-07 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases

Publications (3)

Publication Number Publication Date
JP2011509282A JP2011509282A (ja) 2011-03-24
JP2011509282A5 true JP2011509282A5 (https=) 2012-02-23
JP5587790B2 JP5587790B2 (ja) 2014-09-10

Family

ID=40791443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010541840A Expired - Fee Related JP5587790B2 (ja) 2008-01-09 2009-01-07 化合物

Country Status (4)

Country Link
US (3) US8501744B2 (https=)
EP (2) EP2240491B1 (https=)
JP (1) JP5587790B2 (https=)
WO (1) WO2009087379A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581929B2 (en) * 1985-09-16 1989-03-09 Schering Corporation Antihypertensive agents, pharmaceutical compositions containing them and processes for the preparation of the agents and compositions
GB0817424D0 (en) 2008-09-24 2008-10-29 Medivir Ab Protease inhibitors
EA201590197A1 (ru) 2012-08-23 2015-07-30 Алиос Биофарма, Инк. Соединения для лечения парамиксовирусных вирусных инфекций
WO2014111465A1 (en) 2013-01-17 2014-07-24 Sanofi Isomannide derivatives as inhibitors of soluble epoxide hydrolase
AU2014308991B2 (en) 2013-08-21 2019-02-14 Janssen Biopharma, Inc. Antiviral compounds
MX377396B (es) 2013-09-12 2025-03-10 Janssen Biopharma Inc Compuestos de azapiridona y usos de los mismos.
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444216A (en) 1966-11-16 1969-05-13 Upjohn Co Process for the oxidation of primary and secondary alcohols
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US5128448A (en) 1990-01-10 1992-07-07 Hoffman-La Roche Inc. CCK analogs with appetite regulating activity
US5374623A (en) 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use
CA2111930A1 (en) 1992-12-25 1994-06-26 Ryoichi Ando Aminoketone derivatives
DZ2285A1 (fr) 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
US6043218A (en) 1996-10-22 2000-03-28 Medical University Of South Carolina Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
AR013079A1 (es) 1997-05-06 2000-12-13 Smithkline Beecham Corp Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios
SK6572000A3 (en) 1997-11-05 2000-10-09 Novartis Ag Dipeptide nitriles, process for the preparation thereof, their use as medicaments and pharmaceutical composition comprising them
GB9806287D0 (en) 1998-03-24 1998-05-20 Synphar Lab Inc Monobactam enzyme inhibitors
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
DZ2815A1 (fr) 1998-06-12 2003-12-01 Smithkline Beecham Corp Inhibiteurs de protéase.
JP2003527819A (ja) 1998-08-14 2003-09-24 スミスクライン・ビーチャム・コーポレイション カテプシンｋの阻害方法
ES2142773B1 (es) 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
CO5150165A1 (es) 1998-11-13 2002-04-29 Smithkline Beecham Plc Inhibidores de proteasa: tipo catepsina k
JP2002537293A (ja) 1999-02-20 2002-11-05 アストラゼネカ アクチボラグ カテプシンｌおよび／またはカテプシンｓの阻害剤としてのアセタミドアセトニトリル誘導体
EP1155011A1 (en) 1999-02-20 2001-11-21 AstraZeneca AB Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s
GB9903861D0 (en) 1999-02-20 1999-04-14 Zeneca Ltd Chemical compounds
EP1159273A1 (en) 1999-03-02 2001-12-05 Boehringer Ingelheim Pharmaceuticals Inc. Compounds useful as reversible inhibitors of cathepsin s
HK1039110A1 (zh) 1999-03-15 2002-04-12 Axys Pharmaceuticals, Inc. 以新颖的合成物及组分作为蛋白酶抑制剂
DE60021254T2 (de) 1999-03-15 2006-04-20 AXYS Pharmaceuticals, Inc., South San Francisco N-cyanomethylamide als protease inhibitoren
TW200404789A (en) 1999-03-15 2004-04-01 Axys Pharm Inc Novel compounds and compositions as protease inhibitors
GB9907683D0 (en) 1999-04-06 1999-05-26 Synphar Lab Inc Substituted azetidin-2-ones as cysteine protease inhibitors
GB9911417D0 (en) 1999-05-18 1999-07-14 Peptide Therapeutics Ltd Furanone derivatives as inhibitors of cathepsin s
GB9917909D0 (en) 1999-07-31 1999-09-29 Synphar Lab Inc Cysteine protease inhibitors
US6680836B1 (en) 1999-08-03 2004-01-20 Siemens Aktiengesellschaft Timed tripping circuit for an electromechanical switching device
ES2199856T3 (es) 1999-09-13 2004-03-01 Boehringer Ingelheim Pharmaceuticals, Inc. Nuevos compuestos heterociclicos, utiles como inhibidores reversibles de cisteina proteasas.
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
EP1212302A1 (en) 1999-09-16 2002-06-12 Axys Pharmaceuticals, Inc. Compounds and pharmaceutical compositions as cathepsin s inhibitors
GB9925264D0 (en) 1999-10-26 1999-12-29 Zeneca Ltd Chemical compounds
EP1229911A4 (en) 1999-11-10 2003-05-07 Smithkline Beecham Corp PROTEASE INHIBITORS
WO2001034160A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
ES2270898T3 (es) 1999-12-24 2007-04-16 F. Hoffmann-La Roche Ag Derivados de nitrilo como inhibidores de catepsina k.
DE60132975T2 (de) 2000-01-06 2009-02-26 Merck Frosst Canada Inc., Kirkland Neue substanzen und verbindungen als protease-inhibitoren
GB0003111D0 (en) 2000-02-10 2000-03-29 Novartis Ag Organic compounds
AU2001245764A1 (en) 2000-03-15 2001-09-24 Axys Pharmaceuticals, Inc. Novel compounds and compositions as protease inhibitors
AU2001243441B2 (en) 2000-03-21 2004-11-25 Smithkline Beecham Corporation Protease inhibitors
EP1272467A4 (en) 2000-04-06 2003-05-07 Merck Frosst Canada Inc Cathepsin cysteine protease inhibitors
CO5280093A1 (es) 2000-04-18 2003-05-30 Smithkline Beecham Corp Metodos de tratamiento
NZ522965A (en) 2000-06-14 2004-06-25 Smithkline Beecham Corp Protease inhibitors
US6462076B2 (en) 2000-06-14 2002-10-08 Hoffmann-La Roche Inc. Beta-amino acid nitrile derivatives as cathepsin K inhibitors
WO2002017924A1 (en) 2000-09-01 2002-03-07 Smithkline Beecham Corporation Method of treatment
EP1326848A1 (en) 2000-10-19 2003-07-16 Naeja Pharmaceutical Inc. Dihydropyrimidine derivatives as cysteine protease inhibitors
MXPA03005601A (es) 2000-12-22 2004-12-02 Axys Pharm Inc Nuevos compuestos y composiciones como inhibidores de catepsina.
WO2002057270A1 (en) 2001-01-17 2002-07-25 Amura Therapeutics Limited Inhibitors of cruzipain and other cysteine proteases
IL156776A0 (en) 2001-01-17 2004-02-08 Amura Therapeutics Ltd Inhibitors of cruzipain and other cysteine proteases
WO2002080920A1 (en) 2001-04-06 2002-10-17 Axys Pharmaceuticals, Inc. Arylacetamido-ketobenzoxazole as cysteine protease inhibitors
AU2002342682A1 (en) 2001-05-17 2002-11-25 Smithkline Beecham Corporation Protease inhibitors
FR2826572B1 (fr) 2001-06-29 2005-10-07 Oreal Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles
EP1411933A1 (en) 2001-08-03 2004-04-28 SmithKline Beecham Corporation Alpha-ketoamide derivatives as cathepsin k inhibitors
AR036375A1 (es) 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
JP2005504078A (ja) 2001-09-14 2005-02-10 アベンティス・ファーマスーティカルズ・インコーポレイテツド カテプシン阻害剤としての新規化合物および組成物
CA2459825A1 (en) 2001-10-02 2003-04-10 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases
CA2463770A1 (en) 2001-10-29 2003-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cysteine proteases
WO2003041649A2 (en) 2001-11-13 2003-05-22 Merck Frosst Canada & Co. Cyanoalkylamino derivatives as protease inhibitors
MXPA04004450A (es) 2001-11-14 2004-08-11 Aventis Pharma Inc Nuevos compuestos y composiciones como inhibidores de catepsina s.
WO2004007501A1 (en) 2002-07-16 2004-01-22 Amura Therapeutics Limited Biologically active compounds
AU2005203972B2 (en) 2004-01-08 2010-11-18 Medivir Ab Cysteine protease inhibitors
WO2006064286A1 (en) 2004-12-13 2006-06-22 Medivir Uk Ltd Cathepsin s inhibitors
GB0614042D0 (en) * 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds
GB0614044D0 (en) 2006-07-14 2006-08-23 Amura Therapeutics Ltd Compounds

Similar Documents

Publication Publication Date Title
JP2011509282A5 (https=)
US12377097B2 (en) Aminopyrimidine amide autophagy inhibitors and methods of use thereof
Ries et al. Heterocyclic thrombin inhibitors. Part 2: quinoxalinone derivatives as novel, potent antithrombotic agents
US7638627B2 (en) Process of preparing imatinib and imatinib prepared thereby
TW200745111A (en) New compounds
US9359376B2 (en) Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
JP2010526129A5 (https=)
UA81635C2 (en) 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
BR112020014160A2 (pt) Compostos de benzamida
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
DE602004024375D1 (de) Carboxamidderivate
JP2006509000A5 (https=)
IS8132A (is) Pýrósóló-kínasólín afleiður, aðferð við framleiðslu þeirra og notkun sem kínasa hindrar
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
BRPI0413393A (pt) fexofenadina, composição farmaceuticamente aceitável, método de tratamento antihistamìnico, composição, processo para preparar fexofenadina e uso de fexofenadina
JP2012513390A5 (https=)
RU98108553A (ru) Фармацевтические композиции, содержащие производные гидроксимикоевой кислоты
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
UA85541C2 (ru) Карбаматные производные хинуклидина и фармацевтическая композиции, которая содержит эти соединения
SE0302192D0 (sv) Novel compounds
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
GB0109122D0 (en) Novel compounds
WO2009087379A3 (en) Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases
DE60008399D1 (de) Carbonsäuren und acylsulfonamide, solche verbindungen enthaltende zubereitungen und behandlungsmethoden
EP4490142A2 (en) Pcna inhibitors and uses thereof